sertraline 50 mg daily

DRUG2 trials

Sponsors

VA Office of Research and Development, Johns Hopkins University

Conditions

Generalized Anxiety DisorderPremenstrual Dysphoric Disorder (PMDD)

Phase 4

Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly

CompletedNCT00701675

VA Office of Research and DevelopmentGeneralized Anxiety Disorder

Start: 2005-10-31End: 2009-09-30Updated: 2016-12-29

Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder

RecruitingNCT06704594

Johns Hopkins UniversityPremenstrual Dysphoric Disorder (PMDD)

Start: 2025-05-14End: 2029-07-01Target: 288Updated: 2026-05-07